Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | ANO5 CL E G H | 203859 | 611307 | Limb-girdle muscular dystrophy, type 2L | 611307 | C1969785 | OMIM | 1 | | 972 | 27337 | 608662 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | ANO5 CL E G H | 203859 | 613319 | Miyoshi muscular dystrophy 3 | 613319 | C2750076 | OMIM | 1 | | 972 | 27337 | 608662 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | AR CL E G H | 367 | 313200 | Bulbo-spinal atrophy X-linked | 313200 | C1839259 | OMIM | 1 | | 556 | 644 | 313700 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | CAPN3 CL E G H | 825 | 267 | | | | ORPHA | 1 | | 1288 | 1480 | 114240 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | CAV3 CL E G H | 859 | 614321 | Distal myopathy, Tateyama type | 614321 | C3280443 | OMIM | 1 | | 390 | 1529 | 601253 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | CIDEC CL E G H | 63924 | 435651 | | | | ORPHA | 1 | | 81 | 24229 | 612120 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | DMD CL E G H | 1756 | 98896 | | | | ORPHA | 1 | | 7370 | 2928 | 300377 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | DPM3 CL E G H | 54344 | 263494 | | | | ORPHA | 1 | | 60 | 3007 | 605951 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | FKRP CL E G H | 79147 | 34515 | | | | ORPHA | 1 | | 787 | 17997 | 606596 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | FKRP CL E G H | 79147 | 606612 | Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5 | 606612 | C1847759 | OMIM | 1 | | 787 | 17997 | 606596 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | FKRP CL E G H | 79147 | 607155 | Limb-girdle muscular dystrophy-dystroglycanopathy, type C5 | 607155 | C1846672 | OMIM | 1 | | 787 | 17997 | 606596 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | FKTN CL E G H | 2218 | 253800 | Fukuyama congenital muscular dystrophy | 253800 | C0410174 | OMIM | 1 | | 783 | 3622 | 607440 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | FRG1 CL E G H | 2483 | 158900 | Facioscapulohumeral muscular dystrophy | 158900 | C0238288 | OMIM | 1 | | 126 | 3954 | 601278 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | ISPD CL E G H | 729920 | 616052 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7 | 616052 | C4015095 | OMIM | 1 | | 647 | 37276 | 614631 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | LAMA2 CL E G H | 3908 | 618138 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23 | 618138 | | OMIM | 1 | | 3283 | 6482 | 156225 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | LIMS2 CL E G H | 55679 | 616827 | Muscular dystrophy, limb-girdle, type 2W | 616827 | C4225192 | OMIM | 1 | | 219 | 16084 | 607908 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | LMNA CL E G H | 4000 | 79474 | | | | ORPHA | 1 | | 1622 | 6636 | 150330 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | LTBP4 CL E G H | 8425 | 98896 | | | | ORPHA | 1 | | 540 | 6717 | 604710 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | MAP3K20 CL E G H | 51776 | 617760 | MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION | 617760 | C4540345 | OMIM | 1 | | 243 | 17797 | 609479 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | PLIN1 CL E G H | 5346 | 280356 | | | | ORPHA | 1 | | 101 | 9076 | 170290 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | POMGNT2 CL E G H | 84892 | 618135 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8 | 618135 | CN253928 | OMIM | 1 | | 346 | 25902 | 614828 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 1 | | 737 | 9202 | 607423 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | SGCA CL E G H | 6442 | 608099 | Limb-girdle muscular dystrophy, type 2D | 608099 | C2936332 | OMIM | 1 | | 537 | 10805 | 600119 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 419 | 10806 | 600900 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | SGCD CL E G H | 6444 | 601287 | Limb-girdle muscular dystrophy, type 2F | 601287 | C1832525 | OMIM | 1 | | 587 | 10807 | 601411 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | SGCG CL E G H | 6445 | 353 | Kozlowski Warren Fisher syndrome | | | ORPHA | 1 | | 484 | 10809 | 608896 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | SLC25A1 CL E G H | 6576 | 618197 | MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC | 618197 | | OMIM | 1 | | 505 | 10979 | 190315 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | TCAP CL E G H | 8557 | 601954 | Limb-girdle muscular dystrophy, type 2G | 601954 | C1866008 | OMIM | 1 | | 254 | 11610 | 604488 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 22859 | 12403 | 188840 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | ACTA1 CL E G H | 58 | 2020 | | | | ORPHA | 0 | | 392 | 129 | 102610 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | ANO5 CL E G H | 203859 | 206549 | | | | ORPHA | 0 | | 972 | 27337 | 608662 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | BIN1 CL E G H | 274 | 169189 | | | | ORPHA | 0 | | 552 | 1052 | 601248 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | CHCHD10 CL E G H | 400916 | 615048 | Spinal muscular atrophy, jokela type | 615048 | C3554398 | OMIM | 0 | | 248 | 15559 | 615903 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | DNM2 CL E G H | 1785 | 169189 | | | | ORPHA | 0 | | 885 | 2974 | 602378 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | HACD1 CL E G H | 9200 | 2020 | | | | ORPHA | 0 | | 109 | 9639 | 610467 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | ITGA7 CL E G H | 3679 | 2020 | | | | ORPHA | 0 | | 718 | 6143 | 600536 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | KCNA1 CL E G H | 3736 | 37612 | | | | ORPHA | 0 | | 476 | 6218 | 176260 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | MAP3K20 CL E G H | 51776 | 2020 | | | | ORPHA | 0 | | 243 | 17797 | 609479 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | MTMR14 CL E G H | 64419 | 169189 | | | | ORPHA | 0 | | 156 | 26190 | 611089 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | MYF6 CL E G H | 4618 | 169189 | | | | ORPHA | 0 | | 78 | 7566 | 159991 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | MYL2 CL E G H | 4633 | 2020 | | | | ORPHA | 0 | | 445 | 7583 | 160781 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | PLEC CL E G H | 5339 | 254361 | | | | ORPHA | 0 | | 4152 | 9069 | 601282 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | PMP22 CL E G H | 5376 | 101081 | | | | ORPHA | 0 | | 453 | 9118 | 601097 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | RYR1 CL E G H | 6261 | 169189 | | | | ORPHA | 0 | | 5062 | 10483 | 180901 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | SELENON CL E G H | 57190 | 2020 | | | | ORPHA | 0 | | 537 | 15999 | 606210 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | TPM2 CL E G H | 7169 | 2020 | | | | ORPHA | 0 | | 280 | 12011 | 190990 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | TPM3 CL E G H | 7170 | 2020 | | | | ORPHA | 0 | | 300 | 12012 | 191030 |
HP:0008981 | HP:0008981 | Calf muscle hypertrophy | 0 | TTN CL E G H | 7273 | 178464 | | | | ORPHA | 0 | | 22859 | 12403 | 188840 |